Endocrinopathies: Chronic Thyroiditis, Addison Disease, Pernicious Anemia, Graves’ Disease, Diabetes, and Hypophysitis
暂无分享,去创建一个
A. Steck | G. Eisenbarth | G. Barbesino | Liping Yu | N. Rose | P. Caturegli | C. Burek | A. Ricciuti | A. D. Remigis | L. Vincentiis | Jian Wang | A. Remigis
[1] M. Rewers,et al. GAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes , 2013, Diabetes.
[2] P. Caturegli,et al. From Japan with love: another tessera in the hypophysitis mosaic. , 2013, The Journal of clinical endocrinology and metabolism.
[3] S. Radovick,et al. Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells. , 2013, The Journal of clinical endocrinology and metabolism.
[4] E. Bonifacio,et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. , 2013, JAMA.
[5] G. Barbesino,et al. Clinical Utility of TSH Receptor Antibodies , 2013 .
[6] A. Steck,et al. Proinsulin/Insulin Autoantibodies Measured With Electrochemiluminescent Assay Are the Earliest Indicator of Prediabetic Islet Autoimmunity , 2013, Diabetes Care.
[7] B. Rapoport,et al. Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. , 2013, Thyroid : official journal of the American Thyroid Association.
[8] D. Giavarina,et al. TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis. , 2012, Autoimmunity reviews.
[9] M. Rewers,et al. Distinguishing Persistent Insulin Autoantibodies With Differential Risk , 2011, Diabetes.
[10] P. D. Olivo,et al. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease. , 2011, Thyroid : official journal of the American Thyroid Association.
[11] R. Negro,et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. , 2011, Thyroid : official journal of the American Thyroid Association.
[12] M. Tiemann,et al. Non-specific binding of antibodies in immunohistochemistry: fallacies and facts , 2011, Scientific reports.
[13] S. Hutfless,et al. Significance of prediagnostic thyroid antibodies in women with autoimmune thyroid disease. , 2011, The Journal of clinical endocrinology and metabolism.
[14] M. Rewers,et al. Age of Islet Autoantibody Appearance and Mean Levels of Insulin, but Not GAD or IA-2 Autoantibodies, Predict Age of Diagnosis of Type 1 Diabetes , 2011, Diabetes Care.
[15] R. Núñez Miguel,et al. Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody. , 2011, Journal of molecular endocrinology.
[16] L. Rönnblom,et al. TSGA10 – A Target for Autoantibodies in Autoimmune Polyendocrine Syndrome Type 1 and Systemic Lupus Erythematosus , 2011, Scandinavian journal of immunology.
[17] P. O S I T I O N S T A T E M E N T,et al. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[18] M. Rotondi,et al. Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up. , 2010, The Journal of clinical endocrinology and metabolism.
[19] P. Bingley,et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. , 2010, The Journal of clinical endocrinology and metabolism.
[20] T. Tagami,et al. ORIGINAL ARTICLE: Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample , 2010, Clinical endocrinology.
[21] Shey-Cherng Tzou,et al. Autoimmune hypophysitis: expanding the differential diagnosis to CTLA-4 blockade , 2009, Expert review of endocrinology & metabolism.
[22] V. Rohde,et al. A Radiologic Score to Distinguish Autoimmune Hypophysitis from Nonsecreting Pituitary Adenoma Preoperatively , 2009, American Journal of Neuroradiology.
[23] H. Siljander,et al. Predictive Characteristics of Diabetes-Associated Autoantibodies Among Children With HLA-Conferred Disease Susceptibility in the General Population , 2009, Diabetes.
[24] Jeffrey P. Krischer,et al. Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 , 2009, Diabetes Care.
[25] C. Massart,et al. Clinical value of M22-based assays for TSH-receptor antibody (TRAb) in the follow-up of antithyroid drug treated Graves' disease: comparison with the second generation human TRAb assay. , 2009, Clinica chimica acta; international journal of clinical chemistry.
[26] H. Chase,et al. Diabetic Subjects Diagnosed Through the Diabetes Prevention Trial–Type 1 (DPT-1) Are Often Asymptomatic With Normal A1C at Diabetes Onset , 2009, Diabetes Care.
[27] G. Eisenbarth,et al. Murine high specificity/sensitivity competitive europium insulin autoantibody assay. , 2009, Diabetes technology & therapeutics.
[28] G. Eisenbarth,et al. A Common Nonsynonymous Single Nucleotide Polymorphism in the SLC30A8 Gene Determines ZnT8 Autoantibody Specificity in Type 1 Diabetes , 2008, Diabetes.
[29] G. Eisenbarth,et al. Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays. , 2007, Clinical immunology.
[30] Marian Rewers,et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes , 2007, Proceedings of the National Academy of Sciences.
[31] K. Kamijo. TSH-receptor antibodies determined by the first, second and third generation assays and thyroid-stimulating antibody in pregnant patients with Graves' disease. , 2007, Endocrine journal.
[32] T. Blundell,et al. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. , 2007, Thyroid : official journal of the American Thyroid Association.
[33] P. Caturegli. Autoimmune hypophysitis: an underestimated disease in search of its autoantigen(s). , 2007, The Journal of clinical endocrinology and metabolism.
[34] 田攀文,et al. Autoimmune hypophysitis , 2007 .
[35] T. Hudson,et al. A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.
[36] T. Hökfelt,et al. Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1 , 2007, Proceedings of the National Academy of Sciences.
[37] C. Carella,et al. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period. , 2006, Thyroid : official journal of the American Thyroid Association.
[38] P. Bingley,et al. Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk , 2006, Diabetologia.
[39] Megumi Tanaka,et al. Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. , 2005, Endocrine journal.
[40] C. Betterle,et al. Adrenal cortex autoantibodies in subjects with normal adrenal function. , 2005, Best practice & research. Clinical endocrinology & metabolism.
[41] K. Takano,et al. Rapid differential diagnosis of Graves' disease and painless thyroiditis using total T3/T4 ratio, TSH, and total alkaline phosphatase activity. , 2005, Endocrine journal.
[42] D. Weightman,et al. A new assay for thyrotropin receptor autoantibodies. , 2004, Thyroid : official journal of the American Thyroid Association.
[43] B. Rapoport,et al. Affinity-enrichment of thyrotropin receptor autoantibodies from Graves' patients and normal individuals provides insight into their properties and possible origin from natural antibodies. , 2004, The Journal of clinical endocrinology and metabolism.
[44] T. Blundell,et al. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. , 2004, Thyroid : official journal of the American Thyroid Association.
[45] E. Bonifacio,et al. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. , 2004, The Journal of clinical investigation.
[46] M. Rewers,et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). , 2004, The Journal of clinical endocrinology and metabolism.
[47] M. Rewers,et al. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. , 2004, Diabetes care.
[48] B. Rapoport,et al. Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit. , 2004, The Journal of clinical endocrinology and metabolism.
[49] P. Bingley,et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. , 2004, Diabetes.
[50] T. Takano,et al. Frequent appearance of autoantibodies against prohormone convertase 1/3 and neuroendocrine protein 7B2 in patients with nonfunctioning pituitary macroadenoma , 2003, Endocrine.
[51] C. Betterle,et al. A sensitive non-isotopic assay for GAD65 autoantibodies. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[52] T. Takano,et al. Detection of autoantibodies against the pituitary-specific proteins in patients with lymphocytic hypophysitis. , 2002, European journal of endocrinology.
[53] P. Crock,et al. Identification of the 49-kDa Autoantigen Associated with Lymphocytic Hypophysitis as α-Enolase , 2002 .
[54] T. Takao,et al. Antipituitary Antibodies in Patients with Lymphocytic Hypophysitis , 2002, Hormone Research in Paediatrics.
[55] James W. Thomas,et al. Anergy and not Clonal Ignorance Determines the Fate of B Cells that Recognize a Physiological Autoantigen1 , 2001, The Journal of Immunology.
[56] M. Rewers,et al. Humoral autoreactivity to an alternatively spliced variant of ICA512/IA-2 in Type I diabetes , 2000, Diabetologia.
[57] M. Rewers,et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[58] C. Chapman,et al. Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA. , 1999, Clinical chemistry.
[59] M. Polak,et al. Sera from Children with Type 1 Diabetes mellitus React against a New Group of Antigens Composed of Lysophospholipids , 1999, Hormone Research in Paediatrics.
[60] E. Bonifacio,et al. Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation. , 1999, Journal of immunology.
[61] W. Staines,et al. Reduction of Lipofuscin-like Autofluorescence in Fluorescently Labeled Tissue , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[62] E. Bonifacio,et al. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. , 1999, Diabetes.
[63] O. Pinhas-Hamiel,et al. Type 2 diabetes in adolescents, no longer rare. , 1998, Pediatrics in review.
[64] Watson,et al. A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves' disease , 1998, Clinical endocrinology.
[65] L. Harrison,et al. IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes. , 1998, Human immunology.
[66] T. Kanda,et al. Determination of antipituitary antibody in patients with endocrine disorders by enzyme-linked immunosorbent assay and Western blot analysis. , 1998, The Journal of laboratory and clinical medicine.
[67] J. Lazarus. Prediction of postpartum thyroiditis. , 1998, European journal of endocrinology.
[68] T. Kobayashi,et al. Studies on circulating anti-pituitary antibodies in NIDDM patients. , 1998, Endocrine journal.
[69] H. Chase,et al. Dual-parameter model for prediction of type I diabetes mellitus. , 1998, Proceedings of the Association of American Physicians.
[70] W. Scherbaum,et al. Application of a Bioassay with CHO Cells for the Routine Detection of Stimulating and Blocking Autoantibodies to the TSH-Receptor , 1998, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[71] R. Holman,et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes , 1997, The Lancet.
[72] P. Bingley,et al. A novel micro-assay for insulin autoantibodies. , 1997, Journal of autoimmunity.
[73] S J Gange,et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.
[74] M. Lan,et al. IA-2 and IA-2 beta are major autoantigens in IDDM and the precursors of the 40 kDa and 37 kDa tryptic fragments. , 1996, Journal of autoimmunity.
[75] M. Atkinson,et al. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. , 1996, Journal of immunology.
[76] Roberto Gianani,et al. ICA512 Autoantibody Radioassay , 1995, Diabetes.
[77] S. Ishii,et al. Western blot analysis of rat pituitary antigens recognized by human antipituitary antibodies. , 1995, Endocrine journal.
[78] D. Goldstein,et al. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. , 1994, Journal of immunology.
[79] A. Ziegler,et al. Characterization of Insulin Autoantibodies in Relatives of Patients With Type I Diabetes , 1993, Diabetes.
[80] K. Tokunaga,et al. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406. , 1993, The Journal of clinical endocrinology and metabolism.
[81] P. Crock,et al. Detection of anti-pituitary autoantibodies by immunoblotting. , 1993, Journal of immunological methods.
[82] Å. Lernmark,et al. Autoantibodies in IDDM Primarily Recognize the 65,000-Mr Rather Than 67,000-Mr Isoform of Glutamic Acid Decarboxylase , 1993, Diabetes.
[83] A. Pinchera,et al. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor. , 1993, The Journal of clinical endocrinology and metabolism.
[84] M. Parmentier,et al. Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones. , 1990, Biochemical and biophysical research communications.
[85] S. Baekkeskov,et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase , 1990, Nature.
[86] R. Williams,et al. Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. , 1990, The Journal of clinical investigation.
[87] S. Nagataki,et al. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients. , 1989, The Journal of clinical endocrinology and metabolism.
[88] G. Eisenbarth,et al. Binding of Cytoplasmic Islet Cell Antibodies Is Blocked by Human Pancreatic Glycolipid Extracts , 1988, Diabetes.
[89] A. Pinchera,et al. Measurement of TSAb directly in serum using FRTL-5 cells , 1988, Journal of endocrinological investigation.
[90] J. Konishi,et al. A sensitive and practical assay for thyroid-stimulating antibodies using FRTL-5 thyroid cells. , 1987, Acta endocrinologica.
[91] J. Konishi,et al. A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol. , 1986, The Journal of clinical endocrinology and metabolism.
[92] B. Czarnocka,et al. Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases , 1985, FEBS letters.
[93] V. Rohmer,et al. CIRCULATING PITUITARY AUTOANTIBODIES AGAINST CELLS SECRETING LUTEINISING AND FOLLICLE STIMULATING HORMONES IN CHILDREN WITH CRYPTORCHIDISM , 1984, The Lancet.
[94] B. Smith,et al. A RECEPTOR ASSAY FOR THE MEASUREMENT OF TSH RECEPTOR ANTIBODIES IN UNEXTRACTED SERUM , 1984, Clinical endocrinology.
[95] J. Palmer,et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. , 1983, Science.
[96] S. Filetti,et al. Thyroid-stimulating immunoglobulin bioassay using cultured human thyroid cells. , 1981, The Journal of clinical endocrinology and metabolism.
[97] C. Rotella,et al. Thyroid-stimulating antibody (TSab) detected in sera of Graves' patients using human thyroid cell cultures. , 1980, Clinical and experimental immunology.
[98] J. Konishi,et al. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. , 1978, The Journal of clinical endocrinology and metabolism.
[99] D. Doniach,et al. Binding of human immunoglobulins to pituitary ACTH cells , 1976, Nature.
[100] D. Doniach,et al. AUTOANTIBODIES TO PROLACTIN-SECRETING CELLS OF HUMAN PITUITARY , 1975, The Lancet.
[101] N. Maclaren,et al. ANTIBODY TO CULTURED HUMAN INSULINOMA CELLS IN INSULIN-DEPENDENT DIABETES , 1975, The Lancet.
[102] D. R. Gamble,et al. ISLET-CELL ANTIBODIES IN JUVENILE DIABETES MELLITUS OF RECENT ONSET , 1975, The Lancet.
[103] D. Doniach,et al. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. , 1974, Lancet.
[104] B. Smith,et al. THYROID-STIMULATING IMMUNOGLOBULINS IN GRAVES' DISEASE , 1974 .
[105] L. J. Roth,et al. Thin Sections cut at Temperatures of −70° to −90° C , 1965, Nature.
[106] O. Engelberth,et al. [Autoantibodies in Sheehan's syndrome]. , 1965, Vnitrni lekarstvi.
[107] R. B. Goudie,et al. Anterior hypophysitis and Hashimoto's disease in a young woman. , 1962, The Journal of pathology and bacteriology.
[108] J. Mckenzie. The bioassay of thyrotropin in serum. , 1958, Endocrinology.
[109] P. Gleeson,et al. Autoimmune Gastritis and Pernicious Anemia , 2014 .
[110] C. Betterle,et al. Chapter 42 – Adrenalitis , 2014 .
[111] Jozélio Freire de Carvalho,et al. Autoimmune Addison Disease or Autoimmune Adrenalitis , 2008 .
[112] M. Rewers,et al. Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. , 2007, The Journal of clinical endocrinology and metabolism.
[113] G. Eisenbarth,et al. Type 1 diabetes mellitus of man: genetic susceptibility and resistance. , 2004, Advances in experimental medicine and biology.
[114] K. Usadel,et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. , 1999, The Journal of clinical endocrinology and metabolism.
[115] A. Weetman. Autoimmunity to steroid-producing cells and familial polyendocrine autoimmunity. , 1995, Bailliere's clinical endocrinology and metabolism.
[116] N. Rose,et al. Autoantigenic determinants on human thyroglobulin. II. Determinants recognized by autoantibodies from patients with chronic autoimmune thyroiditis compared to autoantibodies from healthy subjects. , 1990, Clinical immunology and immunopathology.
[117] J. Konishi,et al. A new in vitro assay for human thyroid stimulator using cultured thyroid cells: effect of sodium chloride on adenosine 3',5'-monophosphate increase. , 1982, The Journal of clinical endocrinology and metabolism.